Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Identification of Coronary Vasospasm as a Cause of Recurrent Acute Coronary Syndrome.

Majunke N, von Roeder M, Schürer S, Erbs S.

J Invasive Cardiol. 2018 Oct;30(10):E100.

2.

Differential Diagnosis for an Intracaval Foreign Body.

Majunke N, Unger E, Besler C, Sandri M.

JACC Cardiovasc Interv. 2018 Oct 22;11(20):e171-e172. doi: 10.1016/j.jcin.2018.07.033. Epub 2018 Sep 26. No abstract available.

PMID:
30268873
3.

Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy.

Schürer S, Klingel K, Sandri M, Majunke N, Besler C, Kandolf R, Lurz P, Luck M, Hertel P, Schuler G, Linke A, Mangner N.

JACC Heart Fail. 2017 Jun;5(6):435-445. doi: 10.1016/j.jchf.2017.02.017. Erratum in: JACC Heart Fail. 2017 Aug;5(8):620.

4.

Frequency and clinical course of cerebral embolism in patients undergoing transcatheter left atrial appendage closure.

Majunke N, Eplinius F, Gutberlet M, Moebius-Winkler S, Daehnert I, Grothoff M, Schürer S, Mangner N, Lurz P, Erbs S, Kirsch K, Schuler G, Sandri M.

EuroIntervention. 2017 May 15;13(1):124-130. doi: 10.4244/EIJ-D-16-00776.

PMID:
28218603
5.
6.

Left Atrial Appendage Closure in Patients With Contraindications to Oral Anticoagulation.

Sharma D, Reddy VY, Sandri M, Schulz P, Majunke N, Hala P, Wiebe J, Mraz T, Miller MA, Neuzil P, Möbius-Winkler S, Sievert H, Sick P.

J Am Coll Cardiol. 2016 May 10;67(18):2190-2192. doi: 10.1016/j.jacc.2016.02.053. No abstract available.

7.

Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage With the Watchman Device.

Majunke N, Sandri M, Adams V, Daehnert I, Mangner N, Schuler G, Moebius-Winkler S.

J Invasive Cardiol. 2015 Oct;27(10):448-52. Epub 2015 May 15.

8.

Percutaneous left atrial appendage closure: Technical aspects and prevention of periprocedural complications with the watchman device.

Möbius-Winkler S, Majunke N, Sandri M, Mangner N, Linke A, Stone GW, Dähnert I, Schuler G, Sick PB.

World J Cardiol. 2015 Feb 26;7(2):65-75. doi: 10.4330/wjc.v7.i2.65. Review.

9.

Interventional closure of the left atrial appendage for stroke prevention.

Matsuo Y, Sandri M, Mangner N, Majunke N, Dähnert I, Schuler G, Kurabayashi M, Möbius-Winkler S.

Circ J. 2014;78(3):619-24. Epub 2014 Jan 11.

10.

Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.

Heinisch C, Bertog S, Wunderlich N, Majunke N, Baranowski A, Leetz M, Fischer E, Staubach S, Zimmermann W, Hofmann I, Sievert H.

EuroIntervention. 2012 Oct;8(6):717-23. doi: 10.4244/EIJV8I6A111.

11.

Transcatheter closure of multiple interatrial communications.

Masseli J, Bertog S, Stanczak L, Blankenbach K, Majunke N, Reiffenstein I, Renkhoff K, Lehn K, Wunderlich N, Sievert H.

Catheter Cardiovasc Interv. 2013 Apr;81(5):825-36. doi: 10.1002/ccd.24329. Epub 2012 Aug 20. Review.

PMID:
22907918
12.

Recurrent events after percutaneous closure of patent foramen ovale.

Wallenborn J, Bertog SC, Franke J, Steinberg DH, Majunke N, Wilson N, Wunderlich N, Sievert H.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):541-6. doi: 10.1002/ccd.24511. Epub 2013 Jun 27.

PMID:
22707325
13.

How should I treat a misplaced self-expanding aortic bioprosthetic valve?

Majunke N, Doss M, Steinberg DH, Bargenda S, Plachky J, Rieck B, Wunderlich N, Sievert H.

EuroIntervention. 2010 Sep;6(4):537-42. doi: 10.4244/EIJ30V6I4A88.

PMID:
20884443
14.

Patent foramen ovale closure with the SeptRx device initial experience with the first "In-Tunnel" device.

Zimmermann WJ, Heinisch C, Majunke N, Staubach S, Russell S, Wunderlich N, Sievert H.

JACC Cardiovasc Interv. 2010 Sep;3(9):963-7. doi: 10.1016/j.jcin.2010.04.019.

15.

Device closure of residual shunt after percutaneous closure of patent foramen ovale.

Majunke N, Wallenborn J, Baranowski A, Wunderlich N, Sievert H.

EuroIntervention. 2010 Feb;5(7):833-7.

PMID:
20142199
16.

Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.

Majunke N, Wallenborn J, Wunderlich N, Sievert H.

Minerva Cardioangiol. 2009 Feb;57(1):103-15. Review.

PMID:
19202522
17.

Closure of atrial septal defect with the Amplatzer septal occluder in adults.

Majunke N, Bialkowski J, Wilson N, Szkutnik M, Kusa J, Baranowski A, Heinisch C, Ostermayer S, Wunderlich N, Sievert H.

Am J Cardiol. 2009 Feb 15;103(4):550-4. doi: 10.1016/j.amjcard.2008.10.018. Epub 2008 Dec 25.

PMID:
19195519
18.

A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique.

Majunke N, Baranowski A, Zimmermann W, Heinisch C, Wilson N, Robertson G, Wunderlich N, Sievert H.

Catheter Cardiovasc Interv. 2009 Feb 15;73(3):376-82. doi: 10.1002/ccd.21821.

PMID:
19085919
19.

Percutaneous closure of patent foramen ovale with a novel FlatStent.

Reiffenstein I, Majunke N, Wunderlich N, Carter P, Jones R, Sievert H.

Expert Rev Med Devices. 2008 Jul;5(4):419-25. doi: 10.1586/17434440.5.4.419. Review.

PMID:
18573042
20.

Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder).

Taaffe M, Fischer E, Baranowski A, Majunke N, Heinisch C, Leetz M, Hein R, Bayard Y, Büscheck F, Reschke M, Hoffmann I, Wunderlich N, Wilson N, Sievert H.

Am J Cardiol. 2008 May 1;101(9):1353-8. doi: 10.1016/j.amjcard.2007.12.040. Epub 2008 Mar 10.

PMID:
18435971

Supplemental Content

Loading ...
Support Center